ID:STK4_HUMAN DESCRIPTION: RecName: Full=Serine/threonine-protein kinase 4; EC=2.7.11.1; AltName: Full=Mammalian STE20-like protein kinase 1; Short=MST-1; AltName: Full=STE20-like kinase MST1; AltName: Full=Serine/threonine-protein kinase Krs-2; Contains: RecName: Full=Serine/threonine-protein kinase 4 37kDa subunit; Short=MST1/N; Contains: RecName: Full=Serine/threonine-protein kinase 4 18kDa subunit; Short=MST1/C; FUNCTION: Stress-activated, pro-apoptotic kinase which, following caspase-cleavage, enters the nucleus and induces chromatin condensation followed by internucleosomal DNA fragmentation. Key component of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. STK3/MST2 and STK4/MST1 are required to repress proliferation of mature hepatocytes, to prevent activation of facultative adult liver stem cells (oval cells), and to inhibit tumor formation (By similarity). Phosphorylates 'Ser-14' of histone H2B (H2BS14ph) during apoptosis. Phosphorylates FOXO3 upon oxidative stress, which results in its nuclear translocation and cell death initiation. Phosphorylates MOBKL1A, MOBKL1B and RASSF2. Phosphorylates TNNI3 (cardiac Tn-I) and alters its binding affinity to TNNC1 (cardiac Tn-C) and TNNT2 (cardiac Tn-T). Phosphorylates FOXO1 on 'Ser-212' and regulates its activation and stimulates transcription of PMAIP1 in a FOXO1-dependent manner. Phosphorylates SIRT1 and inhibits SIRT1-mediated p53/TP53 deacetylation, thereby promoting p53/TP53 dependent transcription and apoptosis upon DNA damage. Acts as an inhibitor of PKB/AKT1. Phosphorylates AR on 'Ser-650' and suppresses its activity by intersecting with PKB/AKT1 signaling and antagonizing formation of AR-chromatin complexes. CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein. COFACTOR: Magnesium. ENZYME REGULATION: Inhibited by the C-terminal non-catalytic region. Activated by caspase-cleavage. Full activation also requires homodimerization and autophosphorylation of Thr-183. Activated by RASSF1 which acts by preventing its dephosphorylation. SUBUNIT: Homodimer; mediated via the coiled-coil region. Interacts with NORE1, which inhibits autoactivation. Interacts with and stabilizes SAV1. Interacts with RASSF1. Interacts with FOXO3. Interacts with RASSF2 (via SARAH domain). Interacts with AR, PKB/AKT1, TNNI3 and SIRT1. INTERACTION: Self; NbExp=3; IntAct=EBI-367376, EBI-367376; O95166:GABARAP; NbExp=2; IntAct=EBI-367376, EBI-712001; Q9H0R8:GABARAPL1; NbExp=2; IntAct=EBI-367376, EBI-746969; P60520:GABARAPL2; NbExp=2; IntAct=EBI-367376, EBI-720116; Q9GZQ8:MAP1LC3B; NbExp=7; IntAct=EBI-367376, EBI-373144; P35700:Prdx1 (xeno); NbExp=3; IntAct=EBI-367376, EBI-444948; Q9NS23-2:RASSF1; NbExp=4; IntAct=EBI-367376, EBI-438698; P50749:RASSF2; NbExp=4; IntAct=EBI-367376, EBI-960081; Q86WH2:RASSF3; NbExp=2; IntAct=EBI-367376, EBI-2845202; Q9H2L5:RASSF4; NbExp=3; IntAct=EBI-367376, EBI-2933362; Q8WWW0:RASSF5; NbExp=3; IntAct=EBI-367376, EBI-367390; Q8WWW0-2:RASSF5; NbExp=4; IntAct=EBI-367376, EBI-960502; Q8WWW0-3:RASSF5; NbExp=2; IntAct=EBI-367376, EBI-960507; Q6ZTQ3:RASSF6; NbExp=2; IntAct=EBI-367376, EBI-2933412; Q9H4B6:SAV1; NbExp=6; IntAct=EBI-367376, EBI-1017775; Q13188:STK3; NbExp=3; IntAct=EBI-367376, EBI-992580; Q91VJ4:Stk38 (xeno); NbExp=2; IntAct=EBI-367376, EBI-2527046; SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The caspase-cleaved form cycles between the nucleus and cytoplasm. TISSUE SPECIFICITY: Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Ubiquitously expressed. INDUCTION: Activity increases during mitosis. PTM: Autophosphorylated on serine and threonine residues. Phosphorylation at Thr-120 and Thr-387 by PKB/AKT1, leads to inhibition of its: kinase activity, nuclear translocation and autophosphorylation at Thr-183. It also diminishes its cleavage by caspases and its ability to phosphorylate FOXO3. PTM: Proteolytically cleaved by caspase-3 during apoptosis at Asp- 326 and Asp-349 resulting in a 37 kDa or a 39 kDa subunit respectively. The 39 kDa subunit is further cleaved into the 37 kDa form. Proteolytic cleavage results in kinase activation and nuclear translocation of the truncated form (MST1/N). It is less likely that cleavage at Asp-349 is a prerequisite for activation as this site is not conserved in the murine ortholog. SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily. SIMILARITY: Contains 1 protein kinase domain. SIMILARITY: Contains 1 SARAH domain. SEQUENCE CAUTION: Sequence=AAH29511.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; Sequence=AAH58916.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/STK4ID42440ch20q11.html";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Pfam Domains: PF00069 - Protein kinase domain PF03109 - ABC1 atypical kinase-like domain PF07714 - Protein tyrosine and serine/threonine kinase PF11629 - C terminal SARAH domain of Mst1 PF17667 - Fungal protein kinase
SCOP Domains: 47986 - DEATH domain 56112 - Protein kinase-like (PK-like)
ModBase Predicted Comparative 3D Structure on Q13043
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0000902 cell morphogenesis GO:0001569 branching involved in blood vessel morphogenesis GO:0001841 neural tube formation GO:0001934 positive regulation of protein phosphorylation GO:0003157 endocardium development GO:0006468 protein phosphorylation GO:0006915 apoptotic process GO:0007165 signal transduction GO:0007346 regulation of mitotic cell cycle GO:0007417 central nervous system development GO:0008285 negative regulation of cell proliferation GO:0016310 phosphorylation GO:0018105 peptidyl-serine phosphorylation GO:0023014 signal transduction by protein phosphorylation GO:0030216 keratinocyte differentiation GO:0031098 stress-activated protein kinase signaling cascade GO:0032092 positive regulation of protein binding GO:0033138 positive regulation of peptidyl-serine phosphorylation GO:0035329 hippo signaling GO:0035556 intracellular signal transduction GO:0043065 positive regulation of apoptotic process GO:0045600 positive regulation of fat cell differentiation GO:0046621 negative regulation of organ growth GO:0046777 protein autophosphorylation GO:0050821 protein stabilization GO:0060215 primitive hemopoiesis GO:0060706 cell differentiation involved in embryonic placenta development GO:0060800 regulation of cell differentiation involved in embryonic placenta development GO:0071902 positive regulation of protein serine/threonine kinase activity GO:0090090 negative regulation of canonical Wnt signaling pathway GO:0097284 hepatocyte apoptotic process GO:1902043 positive regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1905461 positive regulation of vascular associated smooth muscle cell apoptotic process
AB209315 - Homo sapiens mRNA for serine/threonine kinase 4 variant protein. BC029511 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone IMAGE:5301283), partial cds. AK225326 - Homo sapiens mRNA for serine/threonine kinase 4 variant, clone: HEP10114. BC015332 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone IMAGE:4400771), partial cds. BC038850 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone IMAGE:5141115), with apparent retained intron. CR933633 - Homo sapiens mRNA; cDNA DKFZp686A2068 (from clone DKFZp686A2068). BC093768 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone MGC:120803 IMAGE:7939613), complete cds. AK315238 - Homo sapiens cDNA, FLJ96240, Homo sapiens serine/threonine kinase 4 (STK4), mRNA. U60207 - Homo sapiens serine/threonine protein kinase Krs-2 mRNA, complete cds. BC058916 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone IMAGE:4390245), partial cds. U18297 - Human MST1 (MST1) mRNA, complete cds. AK309169 - Homo sapiens cDNA, FLJ99210. BC005231 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone IMAGE:3950315), complete cds. BC039023 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone IMAGE:6095545), with apparent retained intron. KJ901769 - Synthetic construct Homo sapiens clone ccsbBroadEn_11163 STK4 gene, encodes complete protein. Z25430 - H.sapiens protein-serine/threonine kinase gene, complete CDS. AY227114 - Homo sapiens kinase/transmembrane domain fusion protein (STK4/SLC36AL fusion) mRNA, partial cds. JD184970 - Sequence 165994 from Patent EP1572962. JD293773 - Sequence 274797 from Patent EP1572962. JD499278 - Sequence 480302 from Patent EP1572962. JD418290 - Sequence 399314 from Patent EP1572962. JD479181 - Sequence 460205 from Patent EP1572962. JD280289 - Sequence 261313 from Patent EP1572962. JD349206 - Sequence 330230 from Patent EP1572962. BC065215 - Homo sapiens cDNA clone IMAGE:5103522, partial cds. JD552600 - Sequence 533624 from Patent EP1572962. DQ587077 - Homo sapiens piRNA piR-54189, complete sequence. DQ590765 - Homo sapiens piRNA piR-57877, complete sequence. JD536913 - Sequence 517937 from Patent EP1572962. JD082011 - Sequence 63035 from Patent EP1572962. AK027088 - Homo sapiens cDNA: FLJ23435 fis, clone HRC12631. BC042861 - Homo sapiens serine/threonine kinase 4, mRNA (cDNA clone IMAGE:5269433). JD523052 - Sequence 504076 from Patent EP1572962. JD513585 - Sequence 494609 from Patent EP1572962. JD257493 - Sequence 238517 from Patent EP1572962. JD219925 - Sequence 200949 from Patent EP1572962. JD219924 - Sequence 200948 from Patent EP1572962. JD183062 - Sequence 164086 from Patent EP1572962.
Biochemical and Signaling Pathways
Reactome (by CSHL, EBI, and GO)
Protein Q13043 (Reactome details) participates in the following event(s):
R-HSA-2028692 Cleavage of p-STK4 (p-MST1) by caspase 3 R-HSA-2028284 Phosphorylation of STK4 (MST1) and SAV1 by STK4 R-HSA-2028555 Phosphorylation of LATS1 and 2 by p-STK4 (p-MST1) R-HSA-2028629 Phosphorylation of MOB1A and B by p-STK4 (p-MST1) R-HSA-2028670 Phosphorylation of MOB1A and B by p-STK4(MST1)/N R-HSA-2028679 Phosphorylation of LATS1 and 2 by p-STK4(MST1)/N R-HSA-2028269 Signaling by Hippo R-HSA-162582 Signal Transduction